Pharmaceutical companies extend patent protections through add-ons

The use of add-on patents has allowed pharmaceutical companies to increase drug patent periods from two years to more than six.

Editor's note: The article correctly reflects the data provided in the source summary.

This article is AI-generated and fact-gated. Original reporting: Ars Technica